Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Alimta by Eli Lilly and Co for Chordoma: Likelihood of Approval
Alimta is under clinical development by Eli Lilly and Co and currently in Phase I for Chordoma. According to GlobalData,...
Data Insights
Alimta by Eli Lilly and Co for Chordoma: Likelihood of Approval
Alimta is under clinical development by Eli Lilly and Co and currently in Phase I for Chordoma. According to GlobalData,...